Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Clinical Trials

Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer

Explore clinical trials studying Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer trial results

Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

NCT04576455

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations: Northwest Georgia Oncology Centers PC - Marietta Marietta, Georgia, United States

University Hospitals Seidman Cancer Center Cleveland, Ohio, United States

Northwest Cancer Specialists - Portland (SW Barnes Rd) Tigard, Oregon, United States

Instituto Angel Roffo Buenos Aires, Argentina

View all 81 locations

View Trial Details

Related conditions